Treatment of Basal Cell Carcinomas With Methyl Aminolevulinate and Daylight

Phase 2

• Conditions: Photodynamic Therapy; Basal Cell Carcinomas

• Registration Number: NCT01349361
• Lead Sponsor: Bispebjerg Hospital

Brief Summary

Photodynamic Therapy (PDT) is an effective treatment of basal cell carcinomas (BCC) however the inconvenience of clinic attendance and discomfort during therapy are significant drawbacks. The objective of this study is to evaluate the effect of daylight-mediated PDT of BCC.

Detailed Description

Not available

Study Timeline

• Status Verified: 2011-03
• Study Start: 2011-03
• Study First Submitted: 2011-05-05
• Study First Submitted QC: 2011-05-05
• Last Update Submitted: 2011-05-05
• Study First Posted: 2011-05-06
• Last Update Posted: 2011-05-06
• Primary Completion: 2013-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• superficial BCC

Exclusion Criteria

• Immunosuppression

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
complete disappearance of the BCC

Trial Locations

Locations (1)

Bispebjerg Hospital; 🇩🇰 Copenhagen NV, Denmark